GlassScriptPhysician profile
Heidi A Lefler
NPI 1184731929
$2,260.88
in general payments reported to CMS, 2019-2025
21 companies · $153 in 2025
The $153 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $499 · 2023: $572 · 2024: $927 · 2025: $153.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,643 · Travel and Lodging: $8.83.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,642.67 |
| Travel and Lodging | $8.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,202.16 | 2022-2025 | |
| Allergan, INC. | $183.33 | 2021-2022 | |
| Astellas Pharma US INC | $143.00 | 2023-2024 | Veozah |
| Radius Health, INC. | $108.11 | 2024 | Tymlos |
| Sumitomo Pharma America, INC. | $78.61 | 2024-2025 | Myfembree |
| Bayer Healthcare Pharmaceuticals INC. | $71.94 | 2021-2022 | |
| Exeltis, USA INC. | $71.66 | 2021-2024 | Slynd |
| Biogen, INC. | $66.61 | 2024 | |
| Avion Pharmaceuticals | $57.50 | 2022 | |
| Therapeuticsmd, INC. | $52.49 | 2021-2022 | |
| Evofem Biosciences, INC. | $34.72 | 2022 | |
| Pfizer INC. | $26.83 | 2022-2023 | |
| Vertex Pharmaceuticals Incorporated | $26.56 | 2025 | |
| Mayne Pharma Commercial LLC | $25.11 | 2023 | |
| Olympus America INC. | $19.02 | 2024 | Olympus |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $18.83 | 2022 | |
| Daiichi Sankyo INC. | $17.38 | 2022 | |
| Solventum Corporation | $16.19 | 2024 | V.A.C. Veraflo, V.A.C. Granufoam, Activ.A.C. |
| Coopersurgical, INC. | $14.04 | 2023 | Paragard T 380a |
| Merck Sharp & Dohme LLC | $13.59 | 2022 | |
| Scynexis, INC. | $13.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Lefler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.